EU for Evibodies

By Kate McDonald
Monday, 09 February, 2009

Arana Therapeutics has been granted an EU patent for its Evibodies range of small antibodies.

Evibodies were part of the technology platform brought into the company by EvoGenix when it merged with Peptech in 2007.

Evibodies are small fragments of a family of proteins that act like antibodies but are about one-tenth smaller.

They were given a US patent in 2007.

By targeting certain pain receptors in the bladder, Australian scientists believe that the...

Positive results for H5 avian influenza (bird flu) have been confirmed in two seabirds found in...

Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced...

Content from other channels on our network

Nestlé launches on-pack date-labelling pilot to help tackle food waste

Handling the protein powder boom: engineering solutions for powder processing

Seafood safety researcher awarded at NZIFST Food Industry Awards

Blade innovation reduces the cost of slicing and dicing

Hygienic Design in Practice: Supporting Modern Food Production

Demand increases for skilled sustainability professionals

Pilot program reduces food waste in SEQ

Yarra Valley Water to report net zero operational emissions

Recycling workers' lives at risk from hazardous waste

Biochar used for solar water purification

Daniel Wyner appointed Lumary CEO

Home care safeguards when disasters hit

"Historic legislation" allows authorised nurses to prescribe PBS medicines

You see what others miss

Tapping into the labour mobility market to fill ongoing workforce gaps